arsenic has been researched along with Symptom Cluster in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Knox, SJ; Li, X; Peehl, DM; Saar, M; Santos, J; Tian, J | 1 |
| Montesinos, P; Sanz, MA | 1 |
| Gnadler, M; Hecht, A; Lengfelder, E; Mezger, J | 1 |
| de Witte, TJ; Jansen, JH; Linssen, PC; Luesink, M; Muus, P; Pennings, JL; Pfundt, R; van der Reijden, BA; Wissink, WM | 1 |
| Rogers, JE; Yang, D | 1 |
| SEIN, M | 1 |
| REYMANN, FE | 1 |
| Benihoud, K; Bobé, P; Bonardelle, D; Chelbi-Alix, MK; Opolon, P | 1 |
| Avivi, I; Gesundheit, B; Ofran, Y; Or, R; Rowe, JM; Zuckerman, T | 1 |
| Hou, KZ; Jin, B; Liu, YP; Yu, P | 1 |
| Cunha De Santis, G; Cunha, FQ; Faccioli, LH; Falcão, RP; Garcia, AB; Lima, AS; Moreno, SE; Rego, EM; Secco, D; Sousa, RB; Tamarozzi, MB | 1 |
| Camacho, LH; Chanel, S; Ellison, R; Heller, G; Ho, R; Scheinberg, DA; Soignet, SL; Warrell, RP | 1 |
| Calleja, E; Coutré, S; Dahlberg, S; Douer, D; Ellison, R; Frankel, SR; Kalaycio, M; Kantarjian, H; Scheinberg, DA; Sievers, EL; Soignet, SL; Steinherz, P; Stone, RM; Tallman, MS; Warrell, RP | 1 |
| Carreras, B; Guirao, A; Jordano, J; Serrano, D | 1 |
| Møller, R; Nielsen, A; Reymann, F | 1 |
| Blanchflower, WJ; Kennedy, S; McMurray, CH; Rice, DA | 1 |
| Happle, R; Hoehn, H | 1 |
2 review(s) available for arsenic and Symptom Cluster
| Article | Year |
|---|---|
How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
Topics: Adult; Arsenic Trioxide; Arsenicals; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Premedication; Syndrome; Tretinoin | 2014 |
Differentiation syndrome in patients with acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Glucocorticoids; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Oxides; Risk Factors; Syndrome; Time Factors; Tretinoin | 2012 |
1 trial(s) available for arsenic and Symptom Cluster
| Article | Year |
|---|---|
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Nervous System Diseases; Oxides; Pilot Projects; Platelet Count; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Syndrome | 2001 |
14 other study(ies) available for arsenic and Symptom Cluster
| Article | Year |
|---|---|
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.
Topics: Animals; Apoptosis; Arsenicals; Cell Cycle Checkpoints; DNA Damage; DNA Repair; Duodenum; Epithelial Cells; Female; Gastrointestinal Tract; Glutathione; Heterografts; Humans; Male; Mice; Prostatic Neoplasms; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Radiation-Sensitizing Agents; Syndrome | 2013 |
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Hypotension; Leukemia, Promyelocytic, Acute; Leukocytosis; Lung Diseases; Oxides; Risk Factors; Severity of Illness Index; Syndrome; Treatment Outcome; Tretinoin | 2017 |
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Topics: Anti-Inflammatory Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Chemokine CCL2; Chemokine CCL24; Chemokine CCL7; Chemokines; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Oligonucleotide Array Sequence Analysis; Oxides; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Syndrome; Tretinoin; Tumor Cells, Cultured | 2009 |
Hepatitis syndrome.
Topics: Arsenicals; Disease; Hepatitis; Hepatitis A; Military Personnel; Syndrome | 1958 |
Are ninth-day erythema and hemorrhagic encephalitis in patients treated with arsenicals parts of one and the same syndrome?
Topics: Arsenicals; Encephalitis; Erythema; Humans; Syndrome | 1950 |
Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cytokines; Drug Evaluation, Preclinical; Enzyme Activation; fas Receptor; Glutathione; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred MRL lpr; Nitric Oxide; Oxidation-Reduction; Oxides; Syndrome | 2006 |
Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Oxides; Pulmonary Alveoli; Respiratory Distress Syndrome; Syndrome | 2007 |
Leukocytosis and retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dyspnea; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Leukocytosis; Male; Middle Aged; Oxides; Remission Induction; Syndrome | 2006 |
Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasm Proteins; Oxides; Phenylbutyrates; Syndrome; Tretinoin; Tumor Cells, Cultured | 2007 |
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dyspnea; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Oxides; Pleural Effusion; Syndrome; Tretinoin | 2000 |
[Bowen's disease of ocular localization caused by chronic exposure to arsenic].
Topics: Arsenic; Arsenic Poisoning; Carcinoma, Squamous Cell; Diabetes Complications; Eye Neoplasms; Humans; Leukemia, Lymphoid; Lipoma; Male; Middle Aged; Occupational Diseases; Precancerous Conditions; Skin Neoplasms; Syndrome | 1978 |
Multiple basal cell carcinoma and internal malignant tumors.
Topics: Aged; Arsenic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Denmark; Female; Humans; Male; Middle Aged; Neoplasms; Precancerous Conditions; Registries; Sex Factors; Skin Neoplasms; Syndrome | 1975 |
Experimental 3-nitro-4-hydroxyphenylarsonic acid toxicosis in pigs.
Topics: Animals; Arsanilic Acid; Arsenic; Arsenic Poisoning; Erythema; Feces; Kidney; Liver; Paraplegia; Roxarsone; Seizures; Swine; Swine Diseases; Syndrome; Time Factors | 1985 |
Cytogenetic studies on cultured fibroblast-like cells derived from basal cell carcinoma tissue.
Topics: Abnormalities, Multiple; Adult; Aged; Arsenic; Carcinoma, Basal Cell; Cells, Cultured; Chromosome Aberrations; Chromosome Disorders; Female; Fibroblasts; Humans; Jaw Diseases; Karyotyping; Lymphocytes; Male; Middle Aged; Odontogenic Cysts; Skin; Skin Neoplasms; Syndrome | 1973 |